By SHANNON O. WELLS
At its Nov. 18 meeting, the Senate Research Committee approved an interim University policy to implement requirements related to dangerous gain-of-function (DGOF) research and international research of concern (IROC), defined as life sciences work that makes or could make a biological agent more harmful, with serious consequences for people, agriculture or the environment.
The policy adoption is a response to the United States Government Policy for Stopping High-Risk Life Sciences Research, issued in July. The policy bars federal funding for DGOF research and IROC, including life sciences research conducted in a country of concern, or conducted abroad by an entity or individual of concern.
The federal government, through the CHIPS and Science Act, determined that research interaction with four countries of concern — China, Russia, Iran and North Korea — will be under additional scrutiny and regulation.
“Effectively, the only one of these countries where (Pitt has) a lot of collaborations now is China,” said Bill Yates, vice chancellor for research protections, on Sept. 16. “The government maintains lists of entities that we need their permission to do business with. There's actually several of these lists out there (and are) continually updated.”
DGOF research is not conducted at the University. Experiments at Pitt that genetically modify infectious agents are already reviewed and approved by the Institutional Biosafety Committee to ensure they are conducted safely. The new policy requires University certification for federal life sciences funding, including the investigator attesting that the proposed work does not include DGOF or potential DGOF research.
Each principal investigator will complete a short screening form before submitting a proposal. If the answers suggest the work could be potential DGOF research, Pitt’s newly formed Institutional Review Entity must review it before the proposal is submitted.
This change moves review from when research is carried out to the moment a proposal is written, Yates explained at the Nov. 18 research meeting. Because relatively few proposals are ultimately funded, this step adds “considerable burden” for the University and its investigators.
“This is just adding on an attestation and a review that the University has to absolutely confirm that a proposal going in is not dangerous gain of function. We tried to do it in the best … and easiest form that we possibly can.”
The form itself can still be tweaked.
“If people have suggestions, please feel free to send them forward,” Yates said, noting a Town Hall held on Nov. 20 to seek community feedback on how to best implement the policy. “(For now) we're having people basically do a self-assessment. Based on that, we can certify that there's (no) dangerous gain of function in a proposal that can move forward.”
Possible international research of concern is referred to the Office of Research Security and Trade Compliance for review.
Responding to a Research committee member’s question of how often recertification will be required, Yates said it’s based on each individual proposal.
“That's what it requires, so that we can certify that nothing goes in that's dangerous gain of function.”
Rob Rutenbar, senior vice chancellor for research, said the policy affects “essentially every proposal that touches on life science topics … Imagine if every single (proposal) you ever did had a clinical trial in it?” he asked. “It’s that level of intrusiveness.”
To further illustrate the enormity of the change, Rutenbar noted that the School of Medicine sends in “probably 3,000-ish kind of proposals that touch this. This is why we have to get super-duper out in front of this,” he said, explaining that Yates’s team has tried to build “the most lightweight, are-you-in-this-bucket-or-not kind of screening.”
He acknowledged that many researchers on campus “work with the same tools,” such as recombinant DNA, gene splicing, CRISPR-Cas9, mRNA. “Several of you do this kind of stuff. We want to make sure you know that when one reads somebody's statement of work like the one-page version of the proposal, it doesn't sound like it's gain of function.”
Reiterating that Pitt doesn’t engage in DGOF research, Rutenbar further stressed the need to “protect everybody, which is why we have to get this in really early. I know people aren't going to like that,” he said, noting that the group “could be looking at 250 proposals a month.”
With Pitt “in the same boat as every other major R1” institution, the University is trying to put “the quickest, lightest-weight mechanisms in front of people as quickly as possible. We are also required to have policy … that says how you are doing this stuff,” he said. “… There was almost no wiggle room in what the policy has to say.”
This policy is an interim, which will be followed by a formal policy that will go through the University Senate process.
“Think of this as the 1.0 alpha draft version of the policy,” Rutenbar said. “We'll get this one out because we have to have something in place, and then if we see any twiddles or tweaks based on having it running for a little bit, we'll come back.”
Praising Yate’s team for its efforts in writing and preparing the interim policy, Rutenbar said he’s expecting “many institutions will be doing something exactly the same.”
Pitt, however, is “actually kind of out ahead on this one. I'm personally feeling pretty good about this. I mean, I'm not thrilled with the amount of extra work, but I don't have a choice. None of us has a choice in that,” he acknowledged. “As (Yates) said, we're going to do a lot of work to certify we're not doing something we've never done and weren't intending to do.”
Calling for a vote, the research committee unanimously approved the interim policy.
Shannon O. Wells is a writer for the University Times. Reach him at shannonw@pitt.edu.
Have a story idea or news to share? Share it with the University Times.
Follow the University Times on Facebook.